Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is International Biotechnology Trust PS Ratio?
International Biotechnology TrustLSE:IBT +0.46%36 PS Ratio is 4.46 as of Jul. 26, 2026, which is 35% below its 10-year median of 6.89. GuruFocus rates LSE:IBT with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 930 Biotechnology companies, International Biotechnology Trust ranks better than 68.49% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, International Biotechnology Trust's share price is £10.85.
International Biotechnology Trust's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was £2.43. Hence, International Biotechnology Trust's PS Ratio for today is 4.46.
During the past 13 years, International Biotechnology Trust's highest 3-Year average Revenue per Share Growth Rate was 152.30% per year. The lowest was -47.20% per year. And the median was 8.60% per year.
Back to Basics: PS Ratio
International Biotechnology Trust (LSE:IBT) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
International Biotechnology Trust PS Ratio Related Terms
International Biotechnology Trust PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, International Biotechnology Trust's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Biotechnology Trust PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's PS Ratio distribution charts can be found below:
* The bar in red indicates where International Biotechnology Trust's PS Ratio falls into.
International Biotechnology Trust PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
International Biotechnology Trust's Share Price of today is £10.85.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. International Biotechnology Trust's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was £2.43.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
International Biotechnology Trust (LSE:IBT) has a PS Ratio of 4.46 as of Jul. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on International Biotechnology Trust and its competitors. This is 35% below median its historical median of 6.89. Over the past decade, International Biotechnology Trust's PS Ratio has ranged from 2.74 to 33.88. According to the industry distribution chart, International Biotechnology Trust ranks #293 out of 930 companies in the Biotechnology industry, placing it in the top 31.5%.
Is International Biotechnology Trust's PS Ratio too high?
International Biotechnology Trust's current PS Ratio of 4.46 is 35% below median its 10-year median of 6.89. Over the past 10 years, this metric has ranged from a low of 2.74 to a high of 33.88. The Biotechnology industry median PS Ratio is 9.00. International Biotechnology Trust's value of 4.46 is 50.4% below this industry median. Based on the distribution chart, International Biotechnology Trust ranks #293 out of 930 companies in the Biotechnology industry, which is above the industry midpoint. Overall, International Biotechnology Trust has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, International Biotechnology Trust ranks #293 out of 930 companies for PS Ratio. This puts International Biotechnology Trust in the upper half of its industry. The industry median PS Ratio is 9.00. International Biotechnology Trust's value of 4.46 is 50.4% below this benchmark. Historically, International Biotechnology Trust's own PS Ratio has ranged from 2.74 to 33.88 over the past decade. While the company's 10-year median is 6.89 vs. the industry median of 9.00, International Biotechnology Trust has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.00, based on 930 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. International Biotechnology Trust's current PS Ratio of 4.46 is 50.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on International Biotechnology Trust and its competitors. For the Biotechnology industry, the median PS Ratio is 9.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. International Biotechnology Trust's current PS Ratio is 4.46, which is 35% below median its own 10-year median of 6.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current PS Ratio of 4.46. The current PS Ratio is 4.46, which is 35% below median its 10-year median of 6.89 and 50.4% below the Biotechnology industry median of 9.00. International Biotechnology Trust's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current PS Ratio is 4.46 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
International Biotechnology Trust Business Description
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
36GF Score
Get the complete analysis for LSE:IBT
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IBT has been successfully added to your 
